Gilead, Biogen stand up for women

By Megan Brodie 2 years ago | In Industry
  • 2 years ago

27 June 2022

Two pharmaceutical companies led the way in voicing their objection to the controversial US Supreme Court ruling overturning the landmark 1973 Roe v. Wade ruling that it is a woman’s constitutional right to determine what happens with her body.

Joining leading companies from other sectors, Biogen and Gilead published similar statements supporting their staff and organisations focused on reproductive health.

“Today’s Supreme Court decision overturns aspects of reproductive healthcare,” posted Biogen shortly after the decision was released. “We firmly support equitable access to healthcare including reproductive health and personal choices.

“We are further enhancing our US health insurance benefits to aid any employee affected by this decision. We will continue to advocate for and support our employees through our comprehensive US employee health benefits.

“The Biogen Foundation is also providing a 100 per cent match for employee donations made to organisations focused on reproductive health. These actions remain consistent with our longstanding values and actions on health equity and access for all.”

Gilead also spoke up for women impacted by the decision.

“Earlier today, the US Supreme Court delivered a decision in Dobbs v. Jackson Women’s Health Organization, which overturned the landmark 1973 Roe v. Wade ruling. This decision will have significant implications for women’s healthcare in roughly half of the states across the country – states where many of our colleagues, partner organizations and patients live and work.

“Improving health equity has always been core to our mission, including removing barriers faced by women, transgender individuals and other groups who are disproportionately impacted. This focus has always transcended our innovative medicines.

“As a healthcare organisation, we understand medical decisions are deeply personal, and we believe they should be made by individuals with advice from their physicians. As a company, our goal is to ensure our employees and their dependents have access to the medical services they need, when they need them.

“We have ensured our medical plan covers reimbursement of travel and lodging expenses to cover employees who need to travel out of state in the US to receive medical care related to women’s reproductive health services.

“In addition, the Gilead Foundation will donate $1.5 million in support of organisations focused on reproductive health services. We have also initiated a special matching donation program where the Gilead Foundation will double any contributions made by individual employees up to the limit of $15,000.”

©MedNews 2022

Leave a Reply